Key Trend Reshaping the Population Screening Market in 2025: Innovative Newborn Mass Screening Services In Population Health

What combination of drivers is leading to accelerated growth in the population screening market?
The population screening market is set to expand, driven by the escalating incidence of cancer. This condition involves certain cells in the body multiplying uncontrollably and spreading across various human organs. By allowing for early detection of cancer when it's more manageable and the prognosis is significantly better, population screening plays a critical role. For instance, the American Cancer Society Inc., a volunteer health organization based in the US, reported in January 2023 that the year 2022 saw 608,570 cancer-related deaths, as well as an estimated 1.9 million new cases of cancer. This marked a rise from 606,520 cancer deaths recorded in 2021. Consequently, the increasing incidence of cancer is fueling the growth of the population screening market.

Get Your Population Screening Market Report Here:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

What is the projected compound annual growth rate (CAGR) of the population screening market from 2025 to 2034, and what factors influence it?
In recent times, the market size for population screening has witnessed substantial growth. The market value will increase from $29.31 billion in 2024 to $31.46 billion in 2025, advancing at a compound annual growth rate (CAGR) of 7.3%. The historical growth can be attributed to various factors such as initiatives for preventing diseases, governmental health policies, the escalation of healthcare costs, and heightened disease consciousness.

In the coming years, the market size for population screening is predicted to exhibit a robust growth, anticipating a value of $41.51 billion by 2029 with a compound annual growth rate (CAGR) of 7.2%. Reasons contributing to this projected growth in the forecast period could be the shift towards personalized medicine, a rising elderly population and prevalent chronic diseases, coupled with the integration of AI and data analytics, and the broadening of screening access. The forecast period is also set to witness key advancements encompassing enhanced medical technology, genomics and precision screening, telehealth and remote screening capabilities, panels for multi-disease screening, and strides towards health equity and accessibility.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

What trends are poised to drive the future success of the population screening market?
Leading corporations in the population screening industry are creating innovative services, like newborn mass screening, to magnify early detection and augment infants' health outcomes. Newborn mass screening represents a public health initiative where newborns undergo tests in the early ages following childbirth for numerous genetic, metabolic, hormonal and functional disorders which cannot be initially detected yet could birth serious health issues if left untreated. For example, in May 2024, Shimadzu Techno-Research Inc., an analytical services company under Shimadzu Corporation, a manufacturer of precision tools based out of Japan, initiated a new contract service executing polymerase chain reaction (PCR) testing for extensive newborn mass screening. This service aims to screen for severe combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), disorders which only affect a minor fraction of newborns yet necessitate immediate medical action upon diagnosis.

What are the major segments of the population screening market and their role in driving growth?
The population screening market covered in this report is segmented -

1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation
2) By Gender: Male, Female
3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above
4) By Business: Hospitals, Research Institutes, Diagnostic Labs

Subsegments:
1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment
2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services
3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12587

Which regions are key players in the growth of the population screening market?
North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the key firms paving the way for growth in the population screening market?
Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

What Is Covered In The Population Screening Global Market Report?

• Market Size Forecast: Examine the population screening market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the population screening market for a structured understanding.
• Key Players Overview: Analyze major players in the population screening market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the population screening market.
• Segment Contributions: Evaluate how different segments drive overall growth in the population screening market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the population screening market.
• Industry Challenges: Identify potential risks and obstacles affecting the population screening market.
• Competitive Landscape: Review strategic developments in the population screening market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.